Camurus Ab Quote - 0RD1 | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
UK
LSE
Camurus Ab (0RD1) Share Price

Camurus Ab (0RD1)

101.20

0.00

( 0.00% )

Updated: 11:00:00

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

101.20

Bid

0.00

Offer

0.00

Volume

394

0.00 Day's Range 0.00

101.20 52 Week Range 101.20

Market Cap

Previous Close

101.20

Open

-

Last Trade

Last Trade Time

20:47:02

Financial Volume

-

VWAP

-

Average Volume (3m)

7,380

Shares Outstanding

55,624,000

Dividend Yield

-

PE Ratio

6.57

Earnings Per Share (EPS)

7.76

Revenue

1.72B

Net Profit

431.44M

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.camurus.com

Headquarters

Lund, Swe

Founded

-

Camurus Ab is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker 0RD1. The last closing price for Camurus Ab was SEK101.20. Over the last year, Camurus Ab shares have traded in a share price range of SEK 101.20 to SEK 101.20.

Camurus Ab currently has 55,624,000 shares in issue. The market capitalisation of Camurus Ab is SEK5.63 billion. Camurus Ab has a price to earnings ratio (PE ratio) of 6.57.

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly PR Newswire LUND, Sweden, July 17, 2023 Favorable safety...

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly PR Newswire LUND, Sweden, July 17, 2023 Favorable safety...

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder PR Newswire LUND, Sweden, May 24, 2023 Brixadi is the first treatment for opioid use...

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder PR Newswire LUND, Sweden, May 24, 2023 Brixadi is the first treatment for opioid use...

Braeburn receives new Complete Response Letter for Brixadi in the US

Braeburn receives new Complete Response Letter for Brixadi in the US PR Newswire LUND, Sweden, Dec. 15, 2021 LUND, Sweden, Dec. 15, 2021 /PRNewswire/ -- Camurus AB (NASDAQ STO: CAMX) today...

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease PR Newswire LUND, Sweden, Sept. 16, 2021 LUND, Sweden, Sept. 16, 2021 /PRNewswire/...

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease PR Newswire LUND, Sweden, Sept. 16, 2021 LUND, Sweden, Sept. 16, 2021 /PRNewswire/...

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US PR Newswire LUND, Sweden, June 26, 2021 New PDUFA action date for Brixadi set for 15 December 2021...

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US New PDUFA action date for Brixadi set for 15 December 2021 PR Newswire LUND, Sweden, June 26, 2021...

Camurus announces Braeburn resubmits New Drug Application for Brixadi™ in the US

Camurus announces Braeburn resubmits New Drug Application for Brixadi™ in the US PR Newswire LUND, Sweden, June 15, 2021 LUND, Sweden, June 15, 2021 /PRNewswire/ -- Camurus AB (NASDAQ STO: CAMX...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	101.2	101.2	101.2	1784	101.2	DE
4	0	0	101.2	101.2	101.2	5767	101.2	DE
12	0	0	101.2	101.2	101.2	7380	101.2	DE
26	0	0	101.2	101.2	101.2	7597	101.2	DE
52	0	0	101.2	101.2	101.2	16895	101.2	DE
156	0	0	101.2	101.2	101.2	11227	101.2	DE
260	0	0	101.2	101.2	101.2	7790	101.2	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SCGLSealand Capital Galaxy Limited	0.415p (38.33%)	13.57M
SCESurface Transforms Plc	0.34p (30.77%)	91M
BLUBlue Star Capital Plc	0.0225p (28.57%)	73.32M
CRTACirata Plc	33.00p (24.88%)	393.02k
COBRCobra Resources Plc	1.20p (20.00%)	8.69M
UOGUnited Oil & Gas Plc	0.125p (-34.21%)	115.26M
SYSSysgroup Plc	21.50p (-24.56%)	360.65k
KEFIKefi Gold And Copper Plc	0.524p (-19.63%)	247.82M
GNIPGenip Plc	15.50p (-16.22%)	89.95k
GENLGenel Energy Plc	75.00p (-14.87%)	1.59M
ORCPOracle Power Plc	0.0605p (6.14%)	1.67B
KEFIKefi Gold And Copper Plc	0.524p (-19.63%)	247.82M
NTVONativo Resources Plc	0.0023p (-8.00%)	202.83M
CLONClontarf Energy Plc	0.0335p (-10.67%)	117.55M
UOGUnited Oil & Gas Plc	0.125p (-34.21%)	115.26M

tradernewstip

tradernewstip 5 minutes ago

$CBDW The AI Chatbot Market in 2025: Growth Prospects and the Strategic Expansion of 1606 Corporation (CBDW)
@2desire-growth-prospects-and-the-strategic-expansion-of-1606-corporation-cbdw/

mwab52

mwab52 6 minutes ago

Good morning (RNVA-Land & Team).......🤑😎........ Go (RNVA & Team)

RichieBoy

RichieBoy 13 minutes ago

Did you see where Contrivian received another very prestigious award from the IT industry? Usually holding companies are existential conduits for high net worth individuals. Long shot I know but, you don't suppose Michael Balkin has any connections with Durham Black or whatever Patrick Shutt calls h

tradernewstip

tradernewstip 16 minutes ago

$ILLR News : Creator-Centric Triller: Sean Kim's Strategy for Social Platform Success
Los Angeles, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Triller Group Inc. (Nasdaq: ILLR) ("Triller Group" or "the Company") revealed a momentous milestone in its evolution by introducing the latest iteration of Tril

IB_

IB_ 21 minutes ago

What ya think ??????????

IB_🤴

IB_

IB_ 21 minutes ago

What ya think ??????????

IB_🤴

CanItBThisEZ2Make

CanItBThisEZ2Make 21 minutes ago

BEST SELLERS RANK (BSR) IS 490 56 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

DR. EVIL

DR. EVIL 23 minutes ago

Hong didn't want to cede control to a board of Director. He would've been required to have a board in the NASDAQ. He's always been captain Ahab with his white whale in Google.

Wayne R

Wayne R 32 minutes ago

Every link that you ever complained about works just fine for me.

Have you tried looking at them with a computer instead of a smartphone?

Could be cookies or viruses or is it viri?

Short story long, I suspect that the problem is on your end.

flipper44

flipper44 37 minutes ago

https://investorshub.advfn.com/uimage/uploads/2024/9/10/jayutIMG_0235.jpeg

https://investorshub.advfn.com/uimage/uploads/2024/9/10/rushyIMG_0234.jpeg

flipper44

flipper44 38 minutes ago

STILL TOWING

STILL TOWING 38 minutes ago

Yowza..PT Barnum was right..$$$gomrge$$$...
Million dollar question, how long will it take? Did Ward already spend that money on something else?

n4807g

n4807g 41 minutes ago

Tesla's China-made EV sales drop 4.3% in Nov
https://finance.yahoo.com/news/teslas-china-made-ev-sales-084808333.html

But here's the shocker!

Chinese rival BYD, with its Dynasty and Ocean lineups of EVs and plug-in hybrids, hit yet another monthly record high wit

sharkey1

sharkey1 48 minutes ago

It could happen, if they send a note to the FDA they are now making Vyvanse,
maybe they get the nod to use the
new plant, I heard. if they launch this month Dec. we will see it reflected in the Feb. Fins,

befast

befast 49 minutes ago

Of course, you don't expect the share price to go above 1 on its own merit, do you? Then we get the typical 30% haircut going with any reverse split and we keep sinking until someone competent is steering the ship. Even Black Friday can not lift the share price... ANF, GAP, UA, HBI, all up 4% while

Pickme2

Pickme2 52 minutes ago

Special attention is noted who the participants are in this classic!

wowalters

wowalters 60 minutes ago

Just trying to keep you out of the fire...

cowtown jay

cowtown jay 1 hour ago

It's touching, especially after all this time, that the SEC would initiate an Admin Proceeding against SpongeTech, "...for the protection of investors..." that they never even bothered to identify.

https://www.sec.gov/files/litigation/admin/2024/34-101539.pdf

Would it b

TRUISM

TRUISM 1 hour ago

SilkRoad, when I first invested in KBLB stock, I too had the anticipatory excitement you and some others possess.

Over time I noticed certain repetitive behaviours, which couldn't be denied.

I feel it best to curb ones enthusiasm, when entertaining this stock.

nowwhat2

nowwhat2 1 hour ago

wow

https://investorshub.advfn.com/uimage/uploads/2024/12/3/nthruxrp_121212_2_capt_1130pm_how_drop_wt.jpg

https://investorshub.advfn.com/uimage/uploads/2024/12/3/xntjjxrp_121212_3_30d_1am_wow_rebound.jpg

B_B!

B_B! 1 hour ago

Movie Theater Stocks Rise After Record-Setting Thanksgiving Feast
By Dade Hayes December 2, 2024
...
Spurred by Moana 2‘s debut and strong carryover business for Gladiator II and Wicked, shares in AMC Entertainment, Cinemark, Imax, National CineMedia and Marcus Corp. rose betw

LVerstee

LVerstee 1 hour ago

manibiotech

manibiotech 1 hour ago

Like they did in the first term. Sure

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions